Synapse - Find an Expert

5608 Results

Contemporary lymph node counts during primary retroperitoneal lymph node dissection

Journal Article

Thompson, R. H.; Carver, B. S.; Bosl, G. J.; Bajorin, D.; Motzer, R.; Feldman, D. R.; Reuter, V. E.; Sheinfeld, J.
Urology (2011)

Fulltext@MSK | Save

Tumour-initiating stem-like cells in human prostate cancer exhibit increased NF-κB signalling

Journal Article

Rajasekhar, V. K.; Studer, L.; Gerald, W.; Socci, N. D.; Scher, H. I.
Nature Communications (2011)

Fulltext@MSK | Save

Prognostic factors for progression-free and overall survival with sunitinib targeted therapy and with cytokine as first-line therapy in patients with metastatic renal cell carcinoma

Journal Article

Patil, S.; Figlin, R. A.; Hutson, T. E.; Michaelson, M. D.; Negrier, S.; Kim, S. T.; Huang, X.; Motzer, R. J.
Annals of Oncology (2011)

Fulltext@MSK | Save

Antitumor activity of SNX-2112, a synthetic heat shock protein-90 inhibitor, in Met-amplified tumor cells with or without resistance to selective MET inhibition

Journal Article

Bachleitner-Hofmann, T.; Sun, M. Y.; Chen, C. T.; Liska, D.; Zeng, Z.; Viale, A.; Olshen, A. B.; Mittlboeck, M.; Christensen, J. G.; Rosen, N.; more...
Clinical Cancer Research (2011)

Fulltext@MSK | Save

Clinical characteristics and outcomes of patients with recurrence 5 years after nephrectomy for localized renal cell carcinoma

Journal Article

Adamy, A.; Chong, K. T. ; Chade, D.; Costaras, J.; Russo, G.; Kaag, M. G.; Bernstein, M.; Motzer, R. J.; Russo, P.
Journal of Urology (2011)

Fulltext@MSK | Save

Validation of a kinetic analysis of renal cancer regression and growth following treatment with sunitinib and interferon-alfa (IFN-alpha): Analysis of the pivotal randomized trial

Meeting Abstract

Wilkerson, J.; Stein, W. D.; Kim, S. T.; Huang, X.; Motzer, R. J.; Fojo, A. T.; Bates, S. E.
Journal of Clinical Oncology (2010)

Fulltext@MSK | Save

Total androgen-receptor gene expression inhibitor therapy (TARGET): A phase II trial of neoadjuvant SAHA (S) followed prostatectomy for patients (pts) with high-risk prostate cancer (pc)

Meeting Abstract

Slovin, S. F.; Fine, S.; Nelson, P.; Steinbrecher, J.; Eastham, J.; Coleman, J.; Touijer, K. A.; Carver, B. S.; Laudone, V.; Scher, H. I.
Journal of Clinical Oncology (2010)

Fulltext@MSK | Save

Docetaxel (D) plus high-dose calcitriol versus D plus prednisone (P) for patients (Pts) with progressive castration-resistant prostate cancer (CRPC): Results from the phase III ASCENT2 trial

Meeting Abstract

Scher, H. I.; Chi, K. N.; De Wit, R.; Berry, W. R.; Albers, P.; Henick, B.; Venner, P.; Heidenreich, A.; Chu, L.; Heller, G.
Journal of Clinical Oncology (2010)

Fulltext@MSK | Save

Anti-insulin-like growth factor-1 receptor (IGF-IR) monoclonal antibody cixutumumab plus mammalian target of rapamycin (mTOR) inhibitor temsirolimus in metastatic castration-resistant prostate cancer (CRPC)